1. MacIntyre CR, Mahimbo A, Moa AM, Barnes M. Influenza vaccine as a coronary intervention for prevention of myocardial infarction. Heart. 2016;0:1–4.
2. Warren-Gash C, Bhaskaran K, Hayward A, et al. Circulating Influenza Virus, Climatic Factors, and Acute Myocardial Infarction: A Time Series Study in England and Wales and Hong Kong. JID. 2011;203:1710–8.
3. Warren-Gash C, Smeeth L, Hayward AC. Influenza as a trigger for acute myocardial infarction or death from cardiovascular disease: a systematic review. Lancet Infect Dis. 2009;9:601–10.
4. Kwong JC, Schwartz KL, Campitelli MA, et al. Acute Myocardial Infarction after Laboratory-Confirmed Influenza Infection. NEJM. 2018;378:345–53.
5. Ruane L, Buckley T, Hoo S, et al. Triggering of acute myocardial infarction by respiratory infection. Intern Med J. 2017;47:522–9.
6. Barnes M, Heywood AE, Mahimbo A, et al. Acute myocardial infarction and influenza: A meta-analysis of case-control studies. Heart. 2015;0:1–10.
7. Miller E, Gebretsadik T, Carroll K, et al. Viral etiologies of infant bronchiolitis, croup and upper respiratory illness during 4 consecutive years. Pediatr Infect Dis J. 2013;32:950–5.
8. Howard P, Kleoppel J. Influenza Vaccine for Cardiovascular Risk Reduction. Hosp Pharm. 2013;48:813–7.
9. Ortiz JR, Perut M, Dumolard L, et al. A global review of national influenza immunization policies: Analysis of the 2014 WHO/UNICEF Joint Reporting Form on immunization. Vaccine. 2016;34:5400–5.
10. World Health Organization. Evaluation of influenza vaccine effectiveness: a guide to the design and interpretation of observational studies. Geneva: WHO, 2017.
11. Davis MM, Taubert K, Benin AL, et al. Influenza Vaccination as Secondary Prevention for Cardiovascular Disease. A Science Advisory From the American Heart Association/American College of Cardiology. J Am Coll Cardiol. 2006;48:1498–502.
12. Jones K, Saxon L, Cunningham W, Adams P. Secondary prevention for patients after a myocardial infarction: summary of updated NICE guidance. BMJ. 2013;347:f6544.
13. Ciszewski A, Bilinska ZT, Brydak LB, et al. Influenza vaccination in secondary prevention from coronary ischaemic events in coronary artery disease: FLUCAD study. Eur Heart J. 2008;29:1350–8.
14. Hesbur S, Vakil E, Oetgen W, et al. Influenza and coronary artery disease: Exploring a clinical association with myocardial infarction and analyzing the utility of vaccination in prevention of myocardial infarction. Rev Cardiovasc Med. 2014;15:168–75.
15. Warren-Gash C, Smeeth L, Hayward A. Influenza and myocardial infarction. Expert Rev Cardiovasc Ther. 2010;8:143–6.
16. Frobert O, Gotberg M, Angeras O, et al. Design and rationale for the Influenza vaccination After Myocardial Infarction (IAMI) trial. A registry-based randomized clinical trial. Am Heart J. 2017;189:94–102.
17. Udell JA, Zawi R, Bhatt DL, et al. Association Between Influenza Vaccination and Cardiovascular Outcomes in High-Risk Patients. JAMA. 2013;310:1711–20.
18. Satuan Petugas Imunisasi Persatuan Dokter Spesialis Penyakit Dalam Indonesia. Pedoman Imunisasi pada Orang Dewasa. Jakarta: PB PAPDI; 2021.